M.D. Sass, Inc. - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.

Quarter-by-quarter ownership
M.D. Sass, Inc. ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q4 2020$1,176,000
-79.0%
32,660
-77.2%
0.25%
-81.8%
Q3 2020$5,599,000
+41.2%
142,985
+32.3%
1.39%
+31.9%
Q2 2020$3,964,000
+479.5%
108,070
+254.0%
1.05%
+865.1%
Q1 2019$684,000
-20.9%
30,530
-25.5%
0.11%
-25.9%
Q4 2018$865,00041,0000.15%
Other shareholders
VANECK VECTORS ETF TR shareholders Q4 2018
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders